A phase III study for brexpiprazole in the treatment of agitation in patients with dementia of the Alzheimer's type

Trial Profile

A phase III study for brexpiprazole in the treatment of agitation in patients with dementia of the Alzheimer's type

Planning
Phase of Trial: Phase III

Latest Information Update: 07 Nov 2017

At a glance

  • Drugs Brexpiprazole (Primary)
  • Indications Agitation
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Nov 2017 New trial record
    • 01 Nov 2017 According to a Lundbeck Inc media release, this trial is expected to commence during the first half of 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top